General Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
12/22/16Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 35th Annual Healthcare Conference on January 11, 2017Printer Friendly Version
11/18/16Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney WeekPrinter Friendly Version
11/17/16Keryx Biopharmaceuticals Announces Multiple Scientific Presentations of Phase 3 Trial Results of Ferric Citrate for Iron Deficiency Anemia (IDA) in Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)Printer Friendly Version
11/09/16Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia® (ferric citrate)Printer Friendly Version
11/09/16Keryx Biopharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate UpdatePrinter Friendly Version
11/03/16Keryx Biopharmaceuticals to Webcast its Presentation at Stifel’s 2016 Healthcare Conference on November 15Printer Friendly Version
11/01/16Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2016 Financial Results on Wednesday, November 9, 2016Printer Friendly Version
10/14/16Keryx Biopharmaceuticals Announces Presentations of Data at the American Society of Nephrology Kidney Week 2016 Annual MeetingPrinter Friendly Version
09/21/16Keryx Biopharmaceuticals to Webcast its Presentation at Ladenburg Thalmann’s 2016 Healthcare ConferencePrinter Friendly Version
09/01/16Keryx Biopharmaceuticals to Present at Two Upcoming Investor Healthcare ConferencesPrinter Friendly Version
08/01/16Keryx Biopharmaceuticals Announces Interruption in Supply of Auryxia® (ferric citrate) and Second Quarter 2016 Financial ResultsPrinter Friendly Version
07/29/16Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2016 Financial Results on Monday, August 1, 2016Printer Friendly Version
06/27/16Douglas Jermasek to Join Keryx Biopharmaceuticals as Vice President, Marketing and StrategyPrinter Friendly Version
06/21/16Keryx Biopharmaceuticals Appoints Two New Board Members Printer Friendly Version
06/14/16Keryx Biopharmaceuticals to Present at JMP’s Life Science Conference on Tuesday, June 21Printer Friendly Version
04/28/16Keryx Biopharmaceuticals Announces First Quarter 2016 Financial ResultsPrinter Friendly Version
04/14/16Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2016 Financial Results on Thursday, April 28, 2016Printer Friendly Version
04/01/16Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of DirectorsPrinter Friendly Version
03/29/16Keryx Biopharmaceuticals Announces Positive Top-line Results from Pivotal  Phase 3 Study of Ferric Citrate for the Treatment of Iron Deficiency Anemia  in Adults with Non-Dialysis Dependent Chronic Kidney DiseasePrinter Friendly Version
03/01/16Keryx Biopharmaceuticals to Present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7Printer Friendly Version
02/25/16Keryx Biopharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial ResultsPrinter Friendly Version
02/11/16Keryx Biopharmaceuticals to Host Conference Call on Fourth Quarter and Year End 2015 Financial Results on Thursday, February 25, 2016Printer Friendly Version